Functional gadolinium-based nanoscale systems for cancer theranostics

J Control Release. 2021 Jan 10:329:482-512. doi: 10.1016/j.jconrel.2020.08.064. Epub 2020 Sep 6.

Abstract

Cancer theranostics is a new strategy for combating cancer that integrates cancer imaging and treatment through theranostic agents to provide an efficient and safe way to improve cancer prognosis. Design and synthesis of these cancer theranostic agents are crucial since these agents are required to be biocompatible, tumor-specific, imaging distinguishable and therapeutically efficacious. In this regard, several types of gadolinium (Gd)-based nanomaterials have been introduced to combine different therapeutic agents with Gd to enhance the efficacy of therapeutic agents. At the same time, the entire treatment procedure could be monitored via imaging tools due to incorporation of Gd ions, Gd chelates and Gd/other imaging probes in the theranostic agents. This review aims to overview recent advances in the Gd-based nanomaterials for cancer theranostics and perspectives for Gd nanomaterial-based cancer theranostics are provided.

Keywords: Anticancer efficacy; Cancer imaging; Cancer theranostics; Gadolinium; Nanomaterials.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Contrast Media
  • Gadolinium*
  • Humans
  • Magnetic Resonance Imaging
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / drug therapy
  • Precision Medicine
  • Theranostic Nanomedicine

Substances

  • Contrast Media
  • Gadolinium